Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
As Previously Announced, Reldesemtiv Had No Effect on the Primary Endpoint of Change from Baseline in ALSFRS-R or Key Secondary Endpoints Trial Discontinued…
Site Personnel Reldesemtiv Had No Effect Primary Endpoint Key Secondary Futility Following Second Planned Interim Reveals Site Personnel
Source: biztoc.com